The growth of the enteral feeding devices market is expected to be largely driven by the expansion of home enteral nutrition, the advantages of enteral nutrition over parenteral nutrition, and the growing global aging population, which is more susceptible to chronic diseases.
The development and adoption of innovative and patient-friendly enteral feeding devices is also expected to improve the market penetration and consumer preference for enteral feeding devices across all regions.
Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/12772
- Abbott Nutrition
- ALCOR Scientific
- Applied Medical Technology
- B. Braun Melsungen AG
- Boston Scientific
- CONMED Corporation.
- Cook Medical
- Cardinal Health, Inc.
- Becton, Dickinson and Company
- Fresenius Kabi
- Owens & Minor, Inc. (Halyard Health)
- Nestlé Health Science
- Danone SA
- Vygon SA
- Amsino International, Inc.
- Fuji Systems Corp
- Smiths Medical (Smiths Group)
The US to Remain Prominent Market for Enteral Feeding Devices Manufacturers
High healthcare spending and a strong homecare support infrastructure are among the factors that are expected to continue to drive the market, specifically the enteral pump market, in the US. Increased emphasis on patient mobility and the rapid adoption of such means in the US is estimated to promote the growth of low-profile enteral feeding devices.
However, factors hampering the growth of the enteral feeding devices market include stringent government regulations and reduction in the sales prices of several enteral feeding devices, even though the US already has the lowest average selling price among the seven major markets of enteral feeding devices in the world.
The development and adoption of innovative and patient-friendly enteral feeding devices is also expected to improve the market penetration and consumer preference for enteral feeding devices across all the regions. The growing global aging population and the trend toward homecare feeding are expected to be among the main factors propelling the enteral feeding devices market during the forecast period.
Increase in the prevalence of chronic conditions, such as cancer and premature birth, are also expected to contribute to the increased usage of enteral feeding devices for nutrition.
However, lack of patient education and reimbursement limitations in certain countries are some of the factors that are likely to hamper the adoption of enteral feeding devices. Parenteral feeding devices, which administer nutrition to patients via IV, have been competitors of enteral feeding devices for a long period. Several studies and articles have been published, which compare these two forms of nutrition, however, most physicians prefer enteral nutrition over parenteral nutrition.
Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/12772
Reimbursement Scenario to Remain among Key Influencers
Another major barrier that is restraining the growth of the enteral feeding devices market is the need for companies in the market to invest high amounts for R&D. However, depending upon the segment, entry into the enteral feeding devices market generally requires less extensive technological capabilities as compared to what is being seen in other medical device areas.
This is especially true for enteral feeding devices, such as nasogastric and replacement G-tubes, which are less technologically complicated and have a low R&D cost, due to which they are less difficult to manufacture. On the other hand, enteral feeding devices such as pumps have high R&D costs, require more technical expertise, have stringent approval regulations, and require companies to provide servicing & maintenance.
Accordingly, reimbursement structures present in different regions vary due to socioeconomic influences. Insurance agencies pose a major challenge to enteral feeding devices manufacturers to cut down on their operating funds. To succeed, manufacturers need to recognize that markets are different, and adjust their strategies in different areas to be able to achieve regional expansion.
The manufacturers of enteral feeding devices need to balance their advertising and technical studies to create better prospects. Moreover, they must confirm and effectually place their central product in their offerings in relation of its price intention.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/12772
Established Players Present Extensive Product Portfolios, Number of New Entrants on Rise
The largest and most dynamic firms in the enteral feeding devices market offer comprehensive portfolios of enteral feeding devices. At present, the global enteral feeding devices market is dominated by key players such as Abbott Nutrition, Cardinal Health, Inc., Fresenius Kabi, Halyard Health, Nestlé, and Nutricia.
The less-known players in the enteral feeding devices market include Moog, which has no significance at the global level, however, it is a market leader in Japan. This provides a clear idea of the potential of the penetration of the global enteral feeding devices market.
Although the enteral feeding devices market is mature and highly competitive, most segments are either saturated or nearing saturation. Some of the new players in the enteral feeding devices market stand the chance of obtaining a sizable market share from the major players that are already present in the market, presence of new emerging players nevertheless creates downward pressure on more established enteral feeding devices manufacturers.
Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape
Molecular Diagnostics Market –
Molecular Diagnostics Market Segmentation by Key Players – Novartis AG, Roche Diagnostics, QIAGEN, Siemens Healthcare, Abbott Laboratories, Inc., Gen-Probe, Inc. (Hologic Inc.), Cepheid, Inc., Beckman Coulter, Inc., Becton, Dickinson & Company, Myriad Genetics, Inc., and bioMerieux.
Next-Generation Sequencing Market –
Next Generation Sequencing Market Segmented by(By Application – Whole-genome Sequencing ,Exome Sequencing,Targeted Resequencing,De Novo Sequencing,RNA Sequencing,ChIP Sequencing,Methyl Sequencing,Others);By Technology- Targeted Sequencing & Resequencing,Whole Genome Sequencing,Whole Exome Sequencing.
Ophthalmology devises Market –
Ophthalmology devises Market Segmentation by Key Players – Abbott Medical Optics Inc., Carl Zeiss Meditec AG, Bausch & Lomb Inc., Essilor International S.A, Ziemer Ophthalmic Systems AG and Topcon Corporation.
Intravenous Iron Drugs Market –
Intravenous (IV) Iron Drugs Market Segmentation by Key Players- Actavis, Inc., AMAG Pharmaceuticals, Inc., Galenica Ltd., Fresenius Medical Care AG & Co. KGaA, Vifor Pharma Ltd., American Regent, Inc., Luitpold Pharmaceuticals, Inc., Pharmacosmos A/S, Rockwell Medical Technologies, Inc., and Sanofi.
Syndromes Progressive Ataxia Weakness Disorders Market –
Treatments for Syndromes of Progressive Ataxia and Weakness Disorders Market Segmentation by Key Players- Abbott Laboratories, Acorda Therapeutics Inc., American Regent Inc., Baxter International Inc., Biogen Idec., Bristol-Myers Squibb, Cadila Healthcare Ltd., Eli Lilly and Company, Glaxosmilthkline Plc., Sanofi, Roche Holding Ltd., Pfizer Inc. and Novartis AG.
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.